As part of our strategy to meet unmet medical needs, we seek to enter into licensing arrangements with pharmaceutical and biotechnology companies, as well as academic and non-profit institutions.

We are interested in:

  • In-licensing vector systems for plant-made pharmaceuticals (PMP)
  • In-licensing candidate vaccine proteins, therapeutic proteins, monoclonal antibodies, and other candidate products for human and/or veterinary indications utililizing a variety of manufacuturing and development platforms
  • Partnering on the development and/or implementation of platform technologies to respond to emerging biothreats
  • Partnering in the development and manufacturing of late-stage therapeutic candidates
  • Out-licensing proprietary Caliber technologies and products